AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Assessing the Efficacy of Steroid Treatment of Achalasia

Phase 4

Withdrawn

Conditions: Achalasia

Interventions: Drug: Apo-Prednisone Cordorol, Detasone - Prednisone

First Posted Date: 2013-07-19

Last Posted Date: 2021-11-17

Lead Sponsor: Mayo Clinic

Registration Number: NCT01903486

Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep

Phase 1

Completed

Conditions: Colonic Polyps

Interventions: Drug: Chromoendoscopy (Indigo Carmine)
Other: Control

First Posted Date: 2013-07-17

Last Posted Date: 2015-03-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 21

Registration Number: NCT01901510

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Longitudinal Study of Cognition With Niemann-Pick Disease, Type C

Completed

Conditions: Niemann-Pick Disease, Type C

First Posted Date: 2013-07-16

Last Posted Date: 2016-01-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 70

Registration Number: NCT01899950

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

Not Applicable

Completed

Conditions: Bloodstream Infection
Fungemia
Bacteremia

Interventions: Other: Bacterial culture
Device: FilmArray testing
Other: Susceptibility testing
Behavioral: Antimicrobial Stewardship

First Posted Date: 2013-07-12

Last Posted Date: 2016-03-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 743

Registration Number: NCT01898208

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1

Not Applicable

Completed

Conditions: Pulmonary Embolism

Interventions: Other: Augmented pulse oximetry using incentive spirometer.
Device: Incentive spirometer.

First Posted Date: 2013-07-12

Last Posted Date: 2025-03-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 64

Registration Number: NCT01898637

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia

Phase 1

Completed

Conditions: Esophageal Cancer

Interventions: Device: Self-expandable metal stent

First Posted Date: 2013-07-10

Last Posted Date: 2013-07-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT01894763

Locations: 🇰🇪
Tenwek Hospital, Bomet, Kenya

Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)

Phase 2

Withdrawn

Conditions: Acute Interstitial Nephritis

Interventions: Drug: Omalizumab
Drug: Prednisone

First Posted Date: 2013-07-09

Last Posted Date: 2018-12-06

Lead Sponsor: Mayo Clinic

Registration Number: NCT01893658

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Duct Cell Adenocarcinoma of the Pancreas
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions: Drug: gemcitabine hydrochloride
Drug: fluorouracil
Radiation: radiation therapy
Other: laboratory biomarker analysis

First Posted Date: 2013-07-09

Last Posted Date: 2017-03-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01893294

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery

Phase 1

Completed

Conditions: Hepatic Complication

Interventions: Drug: Cisplatin
Drug: Gemcitabine Hydrochloride
Other: Quality-of-Life Assessment
Drug: Sirolimus

First Posted Date: 2013-06-27

Last Posted Date: 2016-06-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01888302

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Renal Mass Registry

Not Applicable

Completed

Conditions: Renal Cell Carcinoma

Interventions: Other: questionnaire

First Posted Date: 2013-06-27

Last Posted Date: 2020-06-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 141

Registration Number: NCT01887574

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Home Terms & Conditions Privacy Policy